Comment
. 2008 Jan;63(1):125-6; author reply 126-7.
doi: 10.1002/ana.21185.
Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis
- PMID: 17702024
- DOI: 10.1002/ana.21185
Item in Clipboard
Comment
Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis
Ann Neurol.
2008 Jan.
No abstract available
Comment on
-
New natural history of interferon-beta-treated relapsing multiple sclerosis.Ann Neurol. 2007 Apr;61(4):300-6. doi: 10.1002/ana.21102. Ann Neurol. 2007. PMID: 17444502 Clinical Trial.
Similar articles
-
Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.Ann Neurol. 2008 Jan;63(1):126; author reply 126-7. doi: 10.1002/ana.21186. Ann Neurol. 2008. PMID: 17702028 No abstract available.
-
Control of multiple sclerosis relapses with immunomodulating agents.J Neurol Sci. 2007 May 15;256 Suppl 1:S23-8. doi: 10.1016/j.jns.2007.01.060. Epub 2007 Mar 12. J Neurol Sci. 2007. PMID: 17350652 Review.
-
Measuring and management of anti-interferon beta antibodies in subjects with multiple sclerosis.Mult Scler. 2007 Jun;13(5):567-77. doi: 10.1177/1352458506073522. Epub 2007 Feb 16. Mult Scler. 2007. PMID: 17548434 Review.
-
Interferon beta in relapsing-remitting multiple sclerosis: an eight years experience in a specialist multiple sclerosis centre.J Neurol. 2006 Jul;253(7):947-8; author reply 949. doi: 10.1007/s00415-006-0097-z. Epub 2006 Jul 17. J Neurol. 2006. PMID: 16845567 No abstract available.
-
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.Neurology. 2009 Jun 16;72(24):2134; author reply 2134-5. doi: 10.1212/01.wnl.0000349656.65459.5f. Neurology. 2009. PMID: 19528523 No abstract available.
Cited by
-
Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort.Am J Epidemiol. 2014 Jul 15;180(2):160-71. doi: 10.1093/aje/kwu125. Epub 2014 Jun 17. Am J Epidemiol. 2014. PMID: 24939980 Free PMC article.
-
Beta-interferon exposure and onset of secondary progressive multiple sclerosis.Eur J Neurol. 2015 Jun;22(6):990-1000. doi: 10.1111/ene.12698. Epub 2015 Apr 6. Eur J Neurol. 2015. PMID: 25846809 Free PMC article.
-
Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study.Lancet Reg Health Am. 2024 Jan 6;29:100667. doi: 10.1016/j.lana.2023.100667. eCollection 2024 Jan. Lancet Reg Health Am. 2024. PMID: 38269206 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
